Pomalidomide Reduces Severe Epistaxis in Hereditary Bleeding Disease.

Published Date: 15 Dec 2023

In the HHT trial, daily treatment for 24 weeks considerably decreased the frequency of recurrent nosebleeds.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study opens up possibility of bespoke prostate cancer treatment

2.

Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer

3.

The Truth About Apple AirPods

4.

Rising rates of head and neck cancers in England

5.

Cancer screening rates down among American adults


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot